Clinical trial

Radiation Therapy With and Without Combination Chemotherapy in Patients With…

NCT00002840 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00002840
Title Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma
Official title PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Collaborators Medical Research Council
Status Completed
Phase Phase 3
Study type Interventional
Conditions Brain and Central Nervous System Tumors
Intervention type Drug, Radiation
Interventions lomustine, procarbazine hydrochloride, vincristine sulfate, radiation therapy
Enrollment 350
Start date Aug 1, 1996
Primary completion Mar 1, 2002
First posted Jan 22, 2004
Last update posted Jul 10, 2012
Countries Austria, Belgium, Finland, France, Germany, Hungary, Italy, Netherlands, Portugal, Sweden, Switzerland, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies